Skip to Main Content

Paper Details

Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
Molecular and Cellular Pediatrics
8
2021
AIC, AIHA, AIT, B cell, CD40 ligand, CD40 ligand (CD40L) deficiency, CD40L, Daratumumab, IVIG, Immune-mediated cytopenias, LRBA, Patient, anti-CD38 antibody daratumumab, children, cyclosporine A, daratumumab, eculizumab, eltrombopag, girl, hemolytic anemia, immune-mediated cytopenia, intravenous immunoglobulins, lipopolysaccharide-responsive and beige-like anchor protein, lipopolysaccharide-responsive and beige-like anchor protein (LRBA) deficiency, methyprednisolone, patients, plasma cell, prednisolone, rituximab, sirolimus, thrombocytopenia
Author NameAffiliation
Charlotte M NiemeyerMedical Centre, University of Freiburg
Charlotte M Niemeyer
Charlotte M NiemeyerGerman Cancer Research Center (DKFZ)
  • 1 - 3

Datasets

Release 1.2